aisencia® and HpH Establish New Development Partnership
On January 14, 2026, aisencia and HpH Institute of Pathology and Hematopathology Hamburg entered into a comprehensive development partnership.
On January 14, 2026, aisencia and HpH Institute of Pathology and Hematopathology Hamburg entered into a comprehensive development partnership.
Our team has successfully implemented Vistaneos, our innovative Laboratory Information System (LIS), at Dermatologikum Hamburg, one of Germany’s leading dermatopathology institutes.
As part of the AI-Path project, aisencia GmbH and the Digital Media Lab at the University of Bremen are joining forces to redefine how pathologists work in the digital age.
aisencia GmbH has been awarded €150,000 in EU funding through the BRE-Up program to further develop its digital, AI-powered software solutions Vistaneos and Cutaneos 80.
We are extremely proud to welcome Pathscan Pty Ltd. from Australia as a strategic partner and investor—alongside industry leaders Dr. Ian Katz and Paul Richard.
We are thrilled to announce an strategic partnership with PathPresenter. This collaboration marks a significant milestone by expanding our offerings to the US market.
This innovative product integrates a laboratory information system, an image management system, and DermPath AI, enabling a seamlessly optimized laboratory workflow.
On October 30-31, 2024, Berlin hosted the Stage Two finals, where aisencia® spectacularly earned double recognition from both b2venture and xdeck, who were impressed by our technology.
We are thrilled to announce that aisencia has been nominated for the Stage Two competition, Europe’s largest university venture event, taking place on October 30-31, 2024 in Berlin.
As part of the 25th anniversary of the EXIST program, a competition was organized to award outstanding start-ups. We are very proud that aisencia won 2nd place in the pre-seed category!
End of content
End of content
© 2025 aisencia® GmbH | Legal notice | Privacy policy |
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information